NO20015378L - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
NO20015378L
NO20015378L NO20015378A NO20015378A NO20015378L NO 20015378 L NO20015378 L NO 20015378L NO 20015378 A NO20015378 A NO 20015378A NO 20015378 A NO20015378 A NO 20015378A NO 20015378 L NO20015378 L NO 20015378L
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
NO20015378A
Other languages
Norwegian (no)
Other versions
NO321361B1 (en
NO20015378D0 (en
Inventor
Puwen Zhang
Eugene A Terefenko
III Horace FLETCHER
Andrew Fensome
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of NO20015378D0 publication Critical patent/NO20015378D0/en
Publication of NO20015378L publication Critical patent/NO20015378L/en
Publication of NO321361B1 publication Critical patent/NO321361B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20015378A 1999-05-04 2001-11-02 Cyclo-carbamate derivatives, their use as a medicament, a pharmaceutical preparation, and the use of the derivatives for the manufacture of medicaments. NO321361B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (3)

Publication Number Publication Date
NO20015378D0 NO20015378D0 (en) 2001-11-02
NO20015378L true NO20015378L (en) 2002-01-03
NO321361B1 NO321361B1 (en) 2006-05-02

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015378A NO321361B1 (en) 1999-05-04 2001-11-02 Cyclo-carbamate derivatives, their use as a medicament, a pharmaceutical preparation, and the use of the derivatives for the manufacture of medicaments.

Country Status (19)

Country Link
EP (1) EP1173426A1 (en)
JP (1) JP2002543193A (en)
KR (1) KR20010114250A (en)
CN (1) CN1145618C (en)
AU (1) AU766428B2 (en)
BG (1) BG106079A (en)
BR (1) BR0010213A (en)
CA (1) CA2371726A1 (en)
CZ (1) CZ20013951A3 (en)
EA (1) EA004512B1 (en)
HU (1) HUP0201609A3 (en)
IL (1) IL146280A0 (en)
MX (1) MXPA01011286A (en)
NO (1) NO321361B1 (en)
NZ (1) NZ515355A (en)
PL (1) PL351127A1 (en)
SG (1) SG114650A1 (en)
SK (1) SK15912001A3 (en)
TR (1) TR200103286T2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2562160C (en) * 2004-04-27 2013-05-28 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
EP1844768A1 (en) * 2005-01-19 2007-10-17 Dainippon Sumitomo Pharma Co., Ltd. Aromatic sulfone compound as aldosterone receptor modulator
JP5470043B2 (en) 2007-10-05 2014-04-16 Msd株式会社 Benzoxazinone derivatives
CN111925353B (en) * 2020-08-31 2022-04-08 苏州大学附属第二医院 Preparation method of 2-thiophenecarbonitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
ATE252560T1 (en) * 1994-12-22 2003-11-15 Ligand Pharm Inc STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS
CA2268953A1 (en) * 1996-10-02 1998-04-09 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
HUP0201609A2 (en) 2002-08-28
EA200101176A1 (en) 2002-04-25
EP1173426A1 (en) 2002-01-23
NO321361B1 (en) 2006-05-02
AU766428B2 (en) 2003-10-16
BG106079A (en) 2002-05-31
BR0010213A (en) 2002-02-19
CN1145618C (en) 2004-04-14
NO20015378D0 (en) 2001-11-02
MXPA01011286A (en) 2003-07-14
EA004512B1 (en) 2004-04-29
CZ20013951A3 (en) 2002-05-15
SG114650A1 (en) 2005-09-28
NZ515355A (en) 2004-02-27
CA2371726A1 (en) 2000-11-09
CN1349517A (en) 2002-05-15
SK15912001A3 (en) 2002-06-04
JP2002543193A (en) 2002-12-17
PL351127A1 (en) 2003-03-24
HUP0201609A3 (en) 2002-12-28
IL146280A0 (en) 2002-07-25
TR200103286T2 (en) 2002-07-22
KR20010114250A (en) 2001-12-31
AU4688600A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
NO20015272L (en) Glucocorticoid receptor modulators
NO20051042L (en) Pyrimidylsulfonamide derivatives as chemokine receptor modulators
DK1284974T3 (en) Triazolyltropane derivatives as CCR5 modulators
NO20013671L (en) Substituted bisyclic derivatives useful as anticancer agents
NO20015314D0 (en) steroid Derivatives
PT1444215E (en) 1,2,4-TRIADIAZOLIO DERIVATIVES AS MELANOCORTINE RECEPTOR MODULATORS
NO20013183D0 (en) Azabicycloalkanes as CCR5 modulators
ATE268776T1 (en) BENZODIAZEPINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS
NO20013456D0 (en) Functionalized heterocycles as chemokine receptor modulators
NO20013997D0 (en) Receptor
DK1027342T3 (en) Cyclopentene derivatives as motilin receptor antagonists
DK1144431T3 (en) 16-Hydroxyestratrienes as selectively active estrogens
DK1347974T3 (en) Aminotriazolopyridine derivatives as adenosine receptor ligands
DK1467998T3 (en) Tetracyclic hetero compounds as estrogen receptor modulators
NO20015378L (en) Cyclocarbamate derivatives as progesterone receptor modulators
NO985972D0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
NO20021295D0 (en) Nikotinsyreacetylcholin receptor
NO20012939L (en) Substituted heterocyclic asyl tripeptides for use as thrombin receptor modulators
NO20032415L (en) Compounds active on glucocorticoid receptor II
HK1043989A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
HK1043789A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
DK1159267T3 (en) N-substituted indolines as estrogenic agents
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ID30106A (en) ENZIMATIC SOLUTION OF SELECTIVE ESTROGENT RECEPTOR MODULATORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application